Status:
COMPLETED
Sarcopenia Physical Activity and Metabolomic
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Sarcopenia
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Muscle failure (sarcopenia or dynapenia) is a factor of frailty and therefore, ultimately, of loss of autonomy in the elderly. Currently, no biomarker of muscle failure has a high sensitivity, specifi...
Detailed Description
Sarcopenia is defined as decreased muscle strength and low muscle quantity or quality. Screening and management of sarcopenia was modified in early 2019 by the European Working Group on Sarcopenia in ...
Eligibility Criteria
Inclusion
- Age greater than or equal to 65 years;
- Patient affiliated or beneficiary of a social security plan;
- Patient having signed a prior informed consent
Exclusion
- presence of a physical or cognitive pathology preventing the performance of the physical activity protocol during 3 months
- Patient with legal protection
Key Trial Info
Start Date :
January 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05199207
Start Date
January 11 2022
End Date
July 5 2022
Last Update
July 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06000